We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A Merck subsidiary could lose patent protection on the popular antibiotic Cubicin next year, after a federal appellate court invalidated four of the company’s five patents on the drug. Read More
Horizon Pharma shareholders have approved the company’s issuance of more than 81.7 million new shares to help fund the Irish drugmaker’s hostile takeover of Depomed. Read More
Mylan’s attempted hostile takeover of Perrigo ended fast and ignominiously Nov. 13, with shareholders of the Irish OTC drugmaker largely spurning the generic giant’s bid for control. Read More
Horizon Pharma CEO Timothy Walbert says the company will re-evaluate its relationship with Express Scripts after the pharmacy benefits manager filed suit against the drugmaker and terminated one of its drug dispensers, Linden Care. Read More
The U.S. Supreme Court has refused to hear patent infringement cases brought by two drugmakers against Apotex, paving the way for the Canadian company to produce a generic version of Benicar. Read More